YOLFTbeta
Alzamend Neuro Inc

Alzamend Neuro Inc

ALZN · NASDAQ · Healthcare / Biotechnology

1.24USD-0.06 (-4.62%)

Price History

Full chart

Market Stats

Previous Close1.30
Open1.37
Day Range1.23 – 1.38
52-Week Range0.84 – 2.68
Volume38.78K
Market Cap8.78M
P/E (TTM)0.00
Forward P/E0.00
EPS-1.91
Dividend Yield0.00%
Beta0.24
50-Day Avg1.55
200-Day Avg1.58

About

Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Stephan Jackman
  • Employees4
  • Headquarters3480 Peachtree Road NE, Atlanta, GA, United States, 30326, USA
  • Websitehttps://www.alzamend.com

Leadership

  • Mr. Stephan JackmanCEO & Director · b. 1976
  • Mr. Milton Charles Ault IIIFounder & Vice Chairman · b. 1970
  • Mr. David J. KatzoffChief Financial Officer · b. 1962
  • Mr. Henry C. W. Nisser Esq.Executive VP, General Counsel & Director · b. 1969
  • Mr. Kenneth S. Cragun CPASenior Vice President of Finance · b. 1961

Financials

Income Statement

Currency: USD2016-04-302017-04-302018-04-302019-04-302020-04-302021-04-302022-04-302023-04-302024-04-302025-04-302026-04-30
Total Revenue---00000000
Cost of Revenue-------23.07K50.74K50.74K-
Gross Profit--------23.07K-50.74K-50.74K-
Operating Expense-------14.85M9.89M4.45M-
Operating Income-69.46K-1.55M-898.00K-5.01M-4.42M-4.95M-12.32M-14.87M-9.94M-4.50M-8.77M
EBITDA--21.50K7.34K-5.01M-4.42M-4.95M-12.31M-14.85M-9.89M-4.45M-8.66M
Net Income-69.46K-1.57M-932.00K-4.86M-4.40M-5.05M-12.36M-14.88M-9.95M-4.51M-8.77M
R&D-275.05K323.40K3.70M1.07M1.31M5.20M7.45M6.46M1.41M3.63M
Interest Expense-00013.93K158.80K46.52K7.70K10.10K18.03K6.62K

Balance Sheet

Currency: USD2016-04-302017-04-302018-04-302019-04-302020-04-302021-04-302022-04-302023-04-302024-04-302025-04-302026-04-30
Total Assets30.61K132.29K2.42M1.50M1.81M2.91M14.52M5.92M631.59K4.60M2.08M
Total Liabilities30.72K717.22K96.72K1.18M992.31K899.64K1.16M2.87M3.23M634.76K1.35M
Total Equity-106-584.93K2.32M316.92K821.71K2.01M13.35M3.05M-2.59M3.97M733.21K
Cash1.14K4.98K545.00K42.61K90.28K1.93M14.06M5.14M376.05K3.95M710.69K
Total Debt3.12K591.26K-79.3362.67335.30K--300.71K--
Net Debt1.98K586.28K-545.00K-42.53K-90.22K-1.59M-14.06M-5.14M-75.33K-3.95M-710.69K

Cash Flow

Currency: USD2016-04-302017-04-302018-04-302019-04-302020-04-302021-04-302022-04-302023-04-302024-04-302025-04-302026-04-30
Operating Cash Flow-18.49K-1.42M-2.05M-1.05M-2.35M-2.71M-6.61M-8.92M-8.27M-6.57M-8.07M
Investing Cash Flow--400.00K-400.00K234.09K105.00K100.92K-106.46K--147.24K-300.00K-
Financing Cash Flow25.34K1.42M2.99M308.72K2.29M4.45M18.85M2003.65M10.44M4.83M
Capital Expenditure000106.46K106.46K106.46K106.46K0147.24K300.00K0
Free Cash Flow-18.49K-1.42M-2.05M-1.05M-2.35M-2.71M-6.72M-8.92M-8.42M-6.87M-8.07M
FCF to OCF100.00%100.00%100.00%100.00%100.00%100.00%101.61%100.00%101.78%104.57%100.00%

Earnings

Report DateJul 31, 2016Oct 31, 2016Jan 31, 2017Apr 30, 2017Jul 31, 2017Oct 31, 2017Jan 31, 2018Apr 30, 2018Jul 31, 2018Oct 31, 2018Jan 31, 2019Apr 30, 2019Jul 31, 2019Oct 31, 2019Jan 31, 2020Apr 30, 2020Jul 31, 2020Dec 29, 2020Apr 30, 2021Jul 29, 2021Sep 13, 2021Dec 13, 2021Mar 15, 2022Jul 19, 2022Sep 13, 2022Dec 12, 2022Mar 15, 2023Jul 27, 2023Sep 13, 2023Dec 15, 2023Mar 25, 2024Jul 27, 2024Sep 11, 2024Dec 11, 2024Mar 10, 2025Jul 22, 2025Sep 10, 2025Dec 9, 2025Mar 11, 2026Jul 22, 2026Sep 10, 2026
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00--33.75-40.50-0.03-94.50-54.00-54.00-60.75-0.04-60.75-29.25-2.75-21.42-3.42-3.19-2.70-0.69-1.95-0.53-0.67-0.56
EPS Actual-0.02-0.02-0.01-0.01-0.00-0.00-0.01-0.01-0.03-0.03-0.01-0.01-0.01-0.01-0.02-0.02-0.02-0.03-0.02-0.01-0.03-54.00-40.50-0.04-40.50-40.50-81.00-40.50-0.04-39.60-34.20-13.35-11.25-3.60-1.71-9.48-1.28-0.30-0.58-0.74-0.68
Surprise----------------------60.00%0.00%-33.33%57.14%25.00%-50.00%33.33%0.00%34.81%-16.92%-385.45%47.48%-5.26%46.40%-251.11%-85.51%84.62%-9.43%-10.45%-21.43%
Timing-------------------After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap8.78M
Enterprise Value1.75M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.00
Price / Book1.61
EPS-1.91
Book Value1.20
Revenue (TTM)0
Gross Profit (TTM)0
EBITDA-8.98M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-163.23%
Return on Assets-76.44%
Shares Outstanding4.83M
Shares Float4.81M
Beta0.24
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 2 analystsTarget 26.00
  • Strong Buy
    1
  • Hold
    1

Ownership Breakdown

Institutions
56.35%
Insiders
2.67%
Retail / Other
40.98%

Top Institutional Holders

  • KMT WEALTH MANAGEMENT, LLC
    1.33M27.54%
  • Geode Capital Management, LLC
    45.68K0.95%
  • Vanguard Fiduciary Trust Co
    21.02K0.44%
  • Morgan Stanley - Brokerage Accounts
    18.00K0.37%
  • Hartland & Co
    10.00K0.21%
  • Tower Research Capital LLC
    6.18K0.13%
  • Citigroup Inc
    5.23K0.11%
  • UBS Group AG
    4.50K0.09%
  • Vanguard Capital Management, LLC
    4.40K0.09%
  • BlackRock Inc
    4370.01%
  • SBI Securities Co Ltd
    220.00%
  • Caitong International Asset Management Co., Limited.
    40.00%
  • HARBOR INVESTMENT ADVISORY, LLC
    10.00%
  • DRW Securities, LLC
    00.00%
  • Virtu Financial LLC
    00.00%
  • XTX Topco Ltd
    00.00%
  • Bank of America Corp
    00.00%

Top Fund Holders

  • Fidelity Extended Market Index
    19.96K0.41%
  • Fidelity Series Total Market Index
    4.64K0.10%

Stock Splits

  • May 12, 20251:9
  • Jul 16, 20241:10
  • Oct 31, 20231:15